Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency.
Nicola UghiDavide Paolo BernasconiFrancesca Del GaudioArmanda DicuonzoAlessandro MalobertiCristina GiannattasioPaolo TarsiaGiovanna TraviFrancesco ScaglioneFabrizio ColomboMichaela BertuzziAntonella AdinolfiMaria Grazia ValsecchiClaudio RossettiOscar Massimiliano Episnull nullPublished in: Clinical drug investigation (2023)
A 5-day course of remdesivir in association with the standard of care effectively promoted recovery from COVID-19 among non-critical in-hospital patients and had an acceptable safety profile.
Keyphrases
- healthcare
- public health
- end stage renal disease
- coronavirus disease
- newly diagnosed
- chronic kidney disease
- sars cov
- emergency department
- ejection fraction
- prognostic factors
- mental health
- peritoneal dialysis
- electronic health record
- patient reported outcomes
- quality improvement
- social media
- artificial intelligence
- deep learning
- health promotion